首页> 外文期刊>Journal of applied microbiology >Production of a novel bioflocculant MNXY1 by Klebsiella pneumoniae strain NY1 and application in precipitation of cyanobacteria and municipal wastewater treatment
【24h】

Production of a novel bioflocculant MNXY1 by Klebsiella pneumoniae strain NY1 and application in precipitation of cyanobacteria and municipal wastewater treatment

机译:肺炎克雷伯菌NY1菌株生产新型生物絮凝剂MNXY1及其在蓝细菌沉淀和城市污水处理中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: To isolate and characterize the novel bioflocculant-producing bacteria, to optimize the bioflocculant production and to evaluate its potential applications.Methods and Results: Klebsiella pneumoniae strain NY1, a bacterium that produces a novel bioflocculant (MNXY1), was selected on the chemically defined media. It was classified according to the 16S rRNA gene sequence, morphological and microscopic characteristics. MNXY1 was characterized to contain 26% protein and 66% total sugar. The constituent sugar monomers of MNXY1, revealed by NMR analysis, are glucose, galactose and quinovose. Favourable culture conditions for MNXY1 production were determined. Strain NY1 produces a high level (14.9 g l(-1)) of MNXY1. MNXY1 is thermostable and tolerant to the extreme pH. It precipitated 54% of cyanobacteria from laboratory culture and 72% of the total suspended solids from raw wastewater.Conclusions: Strain NY1 was identified to produce a novel bioflocculant MNXY1. The outstanding performance of MNXY1 in practical applications and its availability in copious amounts make it attractive for further investigation and development for industrial scale applications.Significance and Impact of the Study: This is first report for the identification of a quinovose-containing bioflocculant and application of a protein-polysaccharide complex bioflocculant in precipitation of cyanobacteria. These findings suggest that MNXY1 holds great potential for use in management of harmful algae and city wastewater treatment
机译:目的:为了分离和鉴定新型生物絮凝剂产生细菌,优化生物絮凝剂生产并评估其潜在应用。方法和结果:从化学上选择了产生新型生物絮凝剂(MNXY1)的肺炎克雷伯氏菌菌株NY1。定义的媒体。根据16S rRNA基因序列,形态和微观特征对其进行分类。 MNXY1的特征是含有26%的蛋白质和66%的总糖。通过NMR分析揭示的MNXY1的组成糖单体是葡萄糖,半乳糖和喹诺糖。确定了生产MNXY1的有利培养条件。 NY1菌株产生高含量(14.9 g l(-1))的MNXY1。 MNXY1具有热稳定性,并能耐受极端的pH值。它从实验室培养物中沉淀出了54%的蓝细菌,从原废水中沉淀出了72%的总悬浮固体。结论:鉴定到菌株NY1可生产新型生物絮凝剂MNXY1。 MNXY1在实际应用中的出色性能及其大量供应使其对工业规模的应用进行进一步的研究和开发具有吸引力。一种蛋白质-多糖复合生物絮凝剂,用于沉淀蓝细菌。这些发现表明,MNXY1在管理有害藻类和城市废水处理方面具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号